Matthias P Wymann - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Matthias P Wymann

Showing results (71-80 of 80) with videos related to

Pageof 8

Sort By:

You have reached the last page of results.This site can display upto 80 results.

Haematologica|December 15, 2018

New molecular and therapeutic insights into canine diffuse large B-cell lymphoma elucidates the role of the dog as a model for human diseaseLuca Aresu, Serena Ferraresso, Laura Marconato, et al.

Nature Communications|March 10, 2017

Deconvolution of Buparlisib's mechanism of action defines specific PI3K and tubulin inhibitors for therapeutic interventionThomas Bohnacker, Andrea E Prota, Florent Beaufils, et al.

Nature Cancer|April 28, 2026

Dual targeting of PI3Kγ and STING overcomes regulatory B cell- and myeloid cell-driven immune suppression in pancreatic cancerChengyi Li, Fang Ke, Hongyi Zhao, et al.

Science Signaling|September 11, 2008

Phosphoinositide 3-kinase p110beta activity: key role in metabolism and mammary gland cancer but not developmentElisa Ciraolo, Manuela Iezzi, Romina Marone, et al.

Nature Immunology|July 3, 2024

PI3Kγ in B cells promotes antibody responses and generation of antibody-secreting cellsStephen M Lanahan, Lucas Yang, Kate M Jones, et al.

Molecular Cell|April 9, 2011

Integrating cardiac PIP3 and cAMP signaling through a PKA anchoring function of p110γAlessia Perino, Alessandra Ghigo, Enrico Ferrero, et al.

Nature Communications|September 27, 2019

Human PI3Kγ deficiency and its microbiota-dependent mouse model reveal immunodeficiency and tissue immunopathologyAndrew J Takeda, Timothy J Maher, Yu Zhang, et al.

Cell Reports|October 5, 2024

Nuclear and cytosolic fractions of SOX2 synergize as transcriptional and translational co-regulators of cell fateThorsten Schaefer, Nitish Mittal, Hui Wang, et al.

Cell|September 26, 2002

Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathwaysMichael A Crackower, Gavin Y Oudit, Ivona Kozieradzki, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2017

PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination TherapyChiara Tarantelli, Eugenio Gaudio, Alberto J Arribas, et al.

Pageof 8

Search research articles

Showing results (71-80 of 80) with videos related to

Sort By:

Pageof 8

You have reached the last page of results.This site can display upto 80 results.

Haematologica|December 15, 2018

New molecular and therapeutic insights into canine diffuse large B-cell lymphoma elucidates the role of the dog as a model for human diseaseLuca Aresu, Serena Ferraresso, Laura Marconato, et al.

Nature Communications|March 10, 2017

Deconvolution of Buparlisib's mechanism of action defines specific PI3K and tubulin inhibitors for therapeutic interventionThomas Bohnacker, Andrea E Prota, Florent Beaufils, et al.

Nature Cancer|April 28, 2026

Dual targeting of PI3Kγ and STING overcomes regulatory B cell- and myeloid cell-driven immune suppression in pancreatic cancerChengyi Li, Fang Ke, Hongyi Zhao, et al.

Science Signaling|September 11, 2008

Phosphoinositide 3-kinase p110beta activity: key role in metabolism and mammary gland cancer but not developmentElisa Ciraolo, Manuela Iezzi, Romina Marone, et al.

Nature Immunology|July 3, 2024

PI3Kγ in B cells promotes antibody responses and generation of antibody-secreting cellsStephen M Lanahan, Lucas Yang, Kate M Jones, et al.

Molecular Cell|April 9, 2011

Integrating cardiac PIP3 and cAMP signaling through a PKA anchoring function of p110γAlessia Perino, Alessandra Ghigo, Enrico Ferrero, et al.

Nature Communications|September 27, 2019

Human PI3Kγ deficiency and its microbiota-dependent mouse model reveal immunodeficiency and tissue immunopathologyAndrew J Takeda, Timothy J Maher, Yu Zhang, et al.

Cell Reports|October 5, 2024

Nuclear and cytosolic fractions of SOX2 synergize as transcriptional and translational co-regulators of cell fateThorsten Schaefer, Nitish Mittal, Hui Wang, et al.

Cell|September 26, 2002

Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathwaysMichael A Crackower, Gavin Y Oudit, Ivona Kozieradzki, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2017

PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination TherapyChiara Tarantelli, Eugenio Gaudio, Alberto J Arribas, et al.

Pageof 8